Stereotaxis showcases its remote magnetic navigation technology at TCT symposium

Sep 24 2009

Stereotaxis, Inc. (Nasdaq: STXS) is showcasing the value of its technologies for interventional procedures at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in San Francisco this week. Stereotaxis pioneered remote magnetic navigation in electrophysiology and clinicians have repeatedly demonstrated the value of its technologies in the treatment of cardiac arrhythmias. More than 23,000 cases have been performed with the Magnetic Navigation System, and this clinical experience includes many compelling interventional procedures. In the cath lab as well as the EP lab, Stereotaxis' computer-controlled devices, integrated information systems and advanced networking tools deliver opportunities for hospitals and clinicians to simplify the treatment of complex cases and ultimately aim for enhanced patient care and improved outcomes.

On Monday, September 21, Dr. Gurpreet S. Sandhu of the Mayo Clinic presented data from his use of Stereotaxis' Magnetic Navigation System to treat chronic total occlusions. In his presentation "Beyond Guidewires: What Novel Technologies Help Today?" Dr. Sandhu highlighted the value of the Niobe system in the treatment of failed PCIs . Additionally, Dr. Jeffrey Moses of Columbia University Medical Center presented a live case in which he used the Stereotaxis three-dimensional vessel reconstruction to assist in the treatment of a chronic total occlusion in a patient who had previously undergone open heart surgery.

"Our Niobe System has been used to perform more procedures across the broadest range of cardiovascular applications than any other remote magnetic, robotic or mechanical navigation system presently available," said Michael P. Kaminski, Stereotaxis President and CEO. "In addition to its widespread adoption in EP labs, the Niobe System has been used in the treatment of patients with congenital heart defects and peripheral vascular occlusive disease, and we are very excited about the opportunities we see to extend the value of our magnetic navigation and information management technologies into these and other potential cardio-vascular applications."

At its TCT booth #600, Stereotaxis is showcasing its Pegasus(TM) Magnetic Guidewires and Odyssey(TM) System.

Pegasus Magnetic Guidewires

Stereotaxis recently introduced the Pegasus family of magnetically steerable guidewires. Pegasus is a blended stainless steel and Nitinol(TM) wire that provides exceptional and accurate omni-directional distal tip control. Its clinical advantages include excellent torque control and tip durability; optimal shaft support and device deliverability; and nearly effortless advancement through stenotic and tortuous vessel segments.

The Odyssey System

The Odyssey information backbone will be showcased by demonstrating the new Odyssey QuadHD ultra high resolution display and Odyssey Cinema, which synchronizes and archives lab data and can share a fully integrated view of a procedure with any laptop in the world on a high speed internet connection. This Odyssey portfolio is now designed to integrate standard labs, allowing all labs within a department to leverage the capabilities of remote lab viewing, recording and collaboration.